Literature DB >> 26171046

National burden of colorectal cancer in Lithuania and the ranking of Lithuania within the 45 European nations.

Raimundas Lunevicius1, Tomas Poskus2, Narimantas E Samalavicius3.   

Abstract

The aim of the present paper was to assess the national burden of colorectal cancer in Lithuania, and to determine the performance of Lithuania for the control of colorectal cancer compared with 45 European nations by ranking. Seven sources of data and information were used. The majority of the findings on disease burden are reported in the present study in the form of the crude and age-standardised incidence, age-specific and age-standardised mortality, disability adjusted life years (DALYs), years lived with disability (YLDs) and years of life lost (YLLs) per 100,000 individuals per year by gender and in the two genders combined between 1990 and 2011. Colorectal cancer was ranked as the 3rd leading cause of disease burden out of all malignancies. Overall, the crude incidence was 35 per 100,000 individuals in 2001 and 51 per 100,000 individuals in 2011 in Lithuania. Incidence and mortality from colorectal cancer varied markedly within Lithuania. The number of DALYs and YLLs slightly declined between 2005 and 2010. YLLs contributed 97% of the total burden due to colorectal cancer in 1990, and 96% in 2010. The mortality rate was 4-5 times higher in males aged 50-54 years than in males aged 45-49. The YLDs per 100,000 individuals per year in Lithuania increased by 61.1% between 1990 and 2010. However, Lithuania was below the average of the Central & Eastern, Southern, Northern and Western regions of Europe. It was concluded that the national colorectal cancer service provision should be amplified and that a programme for the prevention and control of colorectal cancer is required.

Entities:  

Keywords:  Lithuania; burden of disease; colorectal cancer; disability-adjusted life years; incidence; mortality

Year:  2015        PMID: 26171046      PMCID: PMC4487151          DOI: 10.3892/ol.2015.3171

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  4 in total

1.  Burden of disease due to cancer in England and Wales.

Authors:  N Jayatilleke; N Pashayan; J W Powles
Journal:  J Public Health (Oxf)       Date:  2011-12-02       Impact factor: 2.341

2.  Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Haidong Wang; Laura Dwyer-Lindgren; Katherine T Lofgren; Julie Knoll Rajaratnam; Jacob R Marcus; Alison Levin-Rector; Carly E Levitz; Alan D Lopez; Christopher J L Murray
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

3.  The pattern of colorectal cancer surgery in Lithuania in 2005: do results meet expectations?

Authors:  Eligijus Poškus; Saulius Mikalauskas; Valdemaras Jotautas; Paulius Žeromskas; Tomas Poškus; Kęstutis Strupas; Narimantas Evaldas Samalavičius; Marius Lasinskas; Andrius Sklepavičius; Algimantas Tamelis; Žilvinas Saladžinskas; Dainius Pavalkis; Audronė Jakaitienė; Giedrė Smailytė
Journal:  Medicina (Kaunas)       Date:  2013       Impact factor: 2.430

4.  UK health performance: findings of the Global Burden of Disease Study 2010.

Authors:  Christopher J L Murray; Michael A Richards; John N Newton; Kevin A Fenton; H Ross Anderson; Charles Atkinson; Derrick Bennett; Eduardo Bernabé; Hannah Blencowe; Rupert Bourne; Tasanee Braithwaite; Carol Brayne; Nigel G Bruce; Traolach S Brugha; Peter Burney; Mukesh Dherani; Helen Dolk; Karen Edmond; Majid Ezzati; Abraham D Flaxman; Tom D Fleming; Greg Freedman; David Gunnell; Roderick J Hay; Sally J Hutchings; Summer Lockett Ohno; Rafael Lozano; Ronan A Lyons; Wagner Marcenes; Mohsen Naghavi; Charles R Newton; Neil Pearce; Dan Pope; Lesley Rushton; Joshua A Salomon; Kenji Shibuya; Theo Vos; Haidong Wang; Hywel C Williams; Anthony D Woolf; Alan D Lopez; Adrian Davis
Journal:  Lancet       Date:  2013-03-05       Impact factor: 79.321

  4 in total
  5 in total

1.  Improved perioperative care is associated with improved long-term survival in colorectal cancer.

Authors:  Eligijus Poskus; Marius Kryzauskas; Tomas Poskus; Saulius Mikalauskas; Narimantas Evaldas Samalavicius; Oleg Aliosin; Sarunas Dailidenas; Algimantas Tamelis; Zilvinas Saladzinskas; Paulius Lizdenis; Audrone Jakaitiene; Giedre Smailyte; Kestutis Strupas
Journal:  Int J Colorectal Dis       Date:  2018-03-12       Impact factor: 2.571

2.  Hand Assisted Laparoscopic Surgery for Colorectal Cancer: Surgical and Oncological Outcomes from a Single Tertiary Referral Centre.

Authors:  Narimantas Evaldas Samalavicius; Zygimantas Kuliesius; Robertas Stasys Samalavičius; Renatas Tikuisis; Edgaras Smolskas; Zilvinas Gricius; Povilas Kavaliauskas; Audrius Dulskas
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

3.  Predictors of Quality of Life Six Years after Curative Colorectal Cancer Surgery: Results of the Prospective Multicenter Study.

Authors:  Gintare Valeikaite-Tauginiene; Agne Kraujelyte; Eligijus Poskus; Valdemaras Jotautas; Zilvinas Saladzinskas; Algimantas Tamelis; Paulius Lizdenis; Audrius Dulskas; Narimantas Evaldas Samalavicius; Kęstutis Strupas; Tomas Poškus
Journal:  Medicina (Kaunas)       Date:  2022-03-26       Impact factor: 2.948

4.  Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not?

Authors:  Narimantas E Samalavicius; Audrius Dulskas; Edita Baltruskeviciene; Giedre Smailyte; Marija Skuciene; Rasa Mikelenaite; Rasa Venslovaite; Eduardas Aleknavicius; Almantas Samalavicius; Raimundas Lunevicius
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2016-12-31       Impact factor: 1.195

5.  Transanal Endoscopic Microsurgery for Patients With Rectal Tumors: A Single Institution's Experience.

Authors:  Audrius Dulskas; Alfredas Kilius; Kestutis Petrulis; Narimantas E Samalavicius
Journal:  Ann Coloproctol       Date:  2017-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.